R-Tech commences RK-023 Phase I study for treatment of eyelash hypotrichosis
R-Tech Ueno is pleased to announce the initiation of a Phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.